The ongoing geopolitical tensions in the Strait of Hormuz are set to hit the pockets of common citizens as pharmaceutical costs are expected to spiral. Disruptions in this vital maritime trade route have severely impacted the global supply chain, leading to a projected 10-20% hike in the prices of medicines and related healthcare products by the end of March.

The Logistics Nightmare: The Strait of Hormuz is a critical gateway for international trade. Due to security threats and the risk of attacks, shipping companies are forced to opt for longer alternative routes, resulting in a steep rise in freight charges and insurance premiums. Since a significant portion of active pharmaceutical ingredients (APIs) and raw materials are imported, the increased logistics cost is being passed on to the consumers.

Impact by Late March: Industry experts warn that patients depending on chronic care medications for diabetes, heart ailments, and chronic infections will feel the pinch the most. The cost increase is not just limited to tablets and capsules but also covers essential medical consumables. While manufacturers are trying to absorb some costs, the prolonged instability in the Middle East makes a significant price revision inevitable in the coming weeks.